96 related articles for article (PubMed ID: 34638842)
1. Cilostazol eliminates radiation-resistant glioblastoma by re-evoking big conductance calcium-activated potassium channel activity.
Liu CC; Wu CL; Yeh IC; Wu SN; Sze CI; Gean PW
Am J Cancer Res; 2021; 11(4):1148-1169. PubMed ID: 33948351
[TBL] [Abstract][Full Text] [Related]
2. FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing.
Li S; Chen Y; Xie Y; Zhan H; Zeng Y; Zeng K; Wang L; Zhan Z; Li C; Zhao L; Chen X; Tan Y; Wang Z; Bu J; Song Y; Deng F; Zhou A
Adv Sci (Weinh); 2023 Nov; 10(33):e2303561. PubMed ID: 37822160
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram: A novel repurposed drug for cancer therapy.
Zeng M; Wu B; Wei W; Jiang Z; Li P; Quan Y; Hu X
Chin Med J (Engl); 2024 Jan; ():. PubMed ID: 38275022
[TBL] [Abstract][Full Text] [Related]
4. Radiation-primed TGF-β trapping by engineered extracellular vesicles for targeted glioblastoma therapy.
Liang R; Lu H; Zhu H; Liang G; Zhang J; Gao J; Tian T
J Control Release; 2024 Jun; 370():821-834. PubMed ID: 38740092
[TBL] [Abstract][Full Text] [Related]
5. Blocking TGF-β- and Epithelial-to-Mesenchymal Transition (EMT)-mediated activation of vessel-associated mural cells in glioblastoma impacts tumor angiogenesis.
Merk L; Regel K; Eckhardt H; Evers M; El-Ayoubi A; Mittelbronn M; Krüger M; Gérardy JJ; Mack AF; Naumann U
Free Neuropathol; 2024 Jan; 5():. PubMed ID: 38455669
[TBL] [Abstract][Full Text] [Related]
6. The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells.
Kucinska M; Pospieszna J; Tang J; Lisiak N; Toton E; Rubis B; Murias M
Biomed Pharmacother; 2024 Jun; 176():116892. PubMed ID: 38876048
[TBL] [Abstract][Full Text] [Related]
7. Thiophene bridged aldehydes (TBAs) image ALDH activity in cells
Maity S; Sadlowski CM; George Lin JM; Chen CH; Peng LH; Lee ES; Vegesna GK; Lee C; Kim SH; Mochly-Rosen D; Kumar S; Murthy N
Chem Sci; 2017 Oct; 8(10):7143-7151. PubMed ID: 29081945
[TBL] [Abstract][Full Text] [Related]
8. The Pivotal Immunomodulatory and Anti-Inflammatory Effect of Histone-Lysine N-Methyltransferase in the Glioma Microenvironment: Its Biomarker and Therapy Potentials.
Richard SA; Eugene KD
Anal Cell Pathol (Amst); 2021; 2021():4907167. PubMed ID: 34745848
[TBL] [Abstract][Full Text] [Related]
9. Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe
Li X; Cheng Y; Yang Z; Ji Q; Huan M; Ye W; Liu M; Zhang B; Liu D; Zhou S
J Nanobiotechnology; 2024 Mar; 22(1):93. PubMed ID: 38443927
[TBL] [Abstract][Full Text] [Related]
10. The TGF-β Family in Glioblastoma.
Golán-Cancela I; Caja L
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256140
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of a tumor microenvironment-responsive disulfiram prodrug and CuO
Cheng FT; Geng YD; Liu YX; Nie X; Zhang XG; Chen ZL; Tang LQ; Wang LH; You YZ; Zhang L
Nanoscale Adv; 2023 Jun; 5(12):3336-3347. PubMed ID: 37325521
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway.
Yuan M; Wu Q; Zhang M; Lai M; Chen W; Yang J; Jiang L; Cao J
J Zhejiang Univ Sci B; 2023 Mar; 24(3):207-220. PubMed ID: 36915997
[TBL] [Abstract][Full Text] [Related]
13. Bulk and Single-Cell Transcriptome Analyses Revealed That the Pyroptosis of Glioma-Associated Macrophages Participates in Tumor Progression and Immunosuppression.
Li L; Wu L; Yin X; Li C; Hua Z
Oxid Med Cell Longev; 2022; 2022():1803544. PubMed ID: 36199426
[TBL] [Abstract][Full Text] [Related]
14. Disulfiram in glioma: Literature review of drug repurposing.
Zhong S; Shengyu Liu ; Xin Shi ; Zhang X; Li K; Liu G; Li L; Tao S; Zheng B; Sheng W; Ye Z; Xing Q; Zhai Q; Ren L; Wu Y; Bao Y
Front Pharmacol; 2022; 13():933655. PubMed ID: 36091753
[TBL] [Abstract][Full Text] [Related]
15. Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy.
Hersh AM; Gaitsch H; Alomari S; Lubelski D; Tyler BM
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954407
[TBL] [Abstract][Full Text] [Related]
16. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen.
Kast RE; Alfieri A; Assi HI; Burns TC; Elyamany AM; Gonzalez-Cao M; Karpel-Massler G; Marosi C; Salacz ME; Sardi I; Van Vlierberghe P; Zaghloul MS; Halatsch ME
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626167
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro.
Jank BJ; Lenz T; Haas M; Kadletz-Wanke L; Campion NJ; Schnoell J; Heiduschka G; Macfelda K
Invest New Drugs; 2022 Jun; 40(3):478-486. PubMed ID: 34985593
[TBL] [Abstract][Full Text] [Related]
18. Disulfiram Sensitizes a Therapeutic-Resistant Glioblastoma to the TGF-β Receptor Inhibitor.
Liu CC; Wu CL; Lin MX; Sze CI; Gean PW
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638842
[TBL] [Abstract][Full Text] [Related]
19. Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.
Triscott J; Lee C; Hu K; Fotovati A; Berns R; Pambid M; Luk M; Kast RE; Kong E; Toyota E; Yip S; Toyota B; Dunn SE
Oncotarget; 2012 Oct; 3(10):1112-23. PubMed ID: 23047041
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
